# Aktis Oncology (AKTS) — Overview

AKTS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/akts

## Price

Last close $16.01 on Oct 15, 2026. 52-week range $15.19 – $32.23.

## Company profile

Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $10.1M |
| Revenue (quarter) | $3.4M |
| Revenue growth (year over year) | 111.37% |
| Gross profit (trailing twelve months) | $10.1M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$73.1M |
| Net income (quarter) | −$24.1M |
| Net income growth (year over year) | -33.58% |
| Net margin | -727.04% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$38.17 |
| Book value per share | $8.76 |
| P/E (trailing twelve months) | — |
| Price to book | 1.8 |
| Debt to assets | 13.05% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Aktis Oncology (AKTS) profitable?

No. Aktis Oncology reported a net loss of $73.1M over the trailing twelve months.

### How much revenue does Aktis Oncology (AKTS) make?

Aktis Oncology generated $10.1M in revenue over the trailing twelve months, up 111.37% year over year.

### How do I buy stock in Aktis Oncology (AKTS)?

AKTS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).